Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results

JF Schäfer, S Gatidis, H Schmidt, B Gückel, I Bezrukov… - Radiology, 2014 - pubs.rsna.org
Purpose To compare positron emission tomography (PET)/magnetic resonance (MR) imaging
and PET/computed tomography (CT) for lesion detection and interpretation, quantification …

[HTML][HTML] Combined PET/MRI: from status quo to status go. Summary report of the fifth international workshop on PET/MR imaging; February 15–19, 2016; Tübingen …

DL Bailey, BJ Pichler, B Gückel, H Barthel… - Molecular imaging and …, 2016 - Springer
This article provides a collaborative perspective of the discussions and conclusions from the
fifth international workshop of combined positron emission tomorgraphy (PET)/magnetic …

A MAGE-A1 HLA-A* 0201 epitope identified by mass spectrometry

S Pascolo, M Schirle, B Gückel, T Dumrese, S Stumm… - Cancer Research, 2001 - AACR
Peptides presented by HLA-A*0201 molecules on the surface of the human breast
carcinoma cell line KS24.22 after IFN-γ induction were analyzed by the “Predict-Calibrate-Detect” …

[HTML][HTML] Is there a link between very early changes of primary and secondary lymphoid organs in 18F-FDG-PET/MRI and treatment response to checkpoint inhibitor …

F Seith, A Forschner, B Weide, B Gückel… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Response assessment or prediction to checkpoint inhibitor therapy (CIT) is an unsolved
problem in current routine diagnostics of patients with melanoma. Here, we evaluated very early …

Combined PET/MR: where are we now? Summary report of the second international workshop on PET/MR imaging April 8–12, 2013, Tubingen, Germany

…, A Drzezga, U Ernemann, C Franzius, B Gückel… - Molecular imaging and …, 2014 - Springer
This workshop was held a year after the initial positron emission tomography/magnetic
resonance (PET/MR) workshop in Tübingen, which was recently reported in this journal. The …

Image‐guided metabolomics and transcriptomics reveal tumour heterogeneity in luminal A and B human breast cancer beyond glucose tracer uptake

…, L Zizmare, A Fischer, B Gückel… - Clinical and …, 2024 - Wiley Online Library
Background Breast cancer is a metabolically heterogeneous disease, and although the
concept of heterogeneous cancer metabolism is known, its precise role in human breast cancer …

[HTML][HTML] Summary report of the first international workshop on PET/MR Imaging, March 19–23, 2012, Tübingen, Germany

…, H Barthel, T Beyer, R Boellaard, B Gückel… - Molecular Imaging and …, 2013 - Springer
We report from the First International Workshop on positron emission tomography/magnetic
resonance imaging (PET/MRI) that was organized by the University of Tübingen in March …

Paclitaxel treatment of breast cancer cell lines modulates Fas/Fas ligand expression and induces apoptosis which can be inhibited through the CD40 receptor

…, M Lindner, G Bastert, D Wallwiener, B Gückel - Oncology, 2004 - karger.com
Objective: Cytotoxic chemotherapy of advanced breast cancer is frequently complicated by
drug resistance. Our goal was to define the role of the apoptosis-regulating receptors Fas (…

Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood …

C Rentzsch, S Kayser, S Stumm, I Watermann… - Clinical cancer …, 2003 - AACR
Purpose: Breast cancers are known to frequently (over)express several well-characterized
tumor-associated antigens (TAAs) such as carcinoembryonic antigen, MUC-1, Her-2/neu, and …

Impact of 18F-FDG-PET/CT on surgical management in patients with advanced melanoma: an outcome based analysis

A Forschner, SC Olthof, B Gückel, P Martus… - European Journal of …, 2017 - Springer
Purpose To evaluate the influence of 18 F-FDG-PET/CT on clinical decision making and
outcome in advanced melanoma patients planned for radical metastasectomy. Methods and …